Creating an AI-ready data foundation for successful AI-enabled drug discovery
Over the past year, we have looked at drug discovery and development from several different...
BioStrand Omics Analysis Blog
Our omics analysis blog brings insights into genetics and genomics research solutions, and their leading role in the development of this industry.
Employee Spotlight with Simon Cuppens
Simon joins the BioStrand team fresh out of university, where he graduated with a Bachelor’s in...
Computational biology and drug discovery: what to expect in 2023
The year 2022 in computational biology was largely marked by two main advancements:
Our most widely read blogs from 2022
It’s been another momentous year for the global life sciences industry. Ever since the pandemic...
Notes from BioTechX 2022
I recently had the privilege of representing the BioStrand Team at BioTechX, Europe’s largest...
Why we love multi-omics analysis
The key challenge to understanding complex biological systems is that they cannot be simply decoded...
Employee Spotlight with Carlo Wouters
Carlo joined Lensai (IPA) as Head of Technology in 2022, bringing with him over two decades of...
Key elements of successful AI-native drug discovery
The use of AI in drug discovery has been progressively expanding over the past decade. Over the...
What is a biomarker?
A biomarker, or biological marker, broadly refers to a range of objectively, accurately, and...
Precision drugs for the precision medicine era
Currently, chemotherapy, using cytotoxic small molecules to kill cancer cells, is the predominant...
Employee Spotlight with Tom Vieijra
In our Employee Spotlight series, we focus on key individuals from our growing network of thought...